The Increlex label and related mitigation literature describe pairing dosing with 30-50 grams of fast-acting carbohydrates within 30 minutes, avoiding fasted or pre-sleep dosing, and maintaining access to glucose tablets during research cycles
How BPC-157 was discovered The story starts in the late 1980s and early 1990s in the gastroenterology department at the University of Zagreb, Croatia, with a research group led by Predrag Sikiric
The molecule may be the same on the label
Fluid retention : GH causes water retention, bloating, and blood pressure increases
If youre deciding rather than stacking, the rough guidelines most clinicians use are: BPC-157 alone patients whose primary issue is gut inflammation, inflammatory bowel conditions, NSAID-induced stomach damage, or broader systemic inflammation where the gut is the focal point
Response from the owner: Thank you so much